SCHEMBL6356129

SCHEMBL6356129

Cc1[nH]c2ccccc2c1CC(=O)N[C@@](C)(C(=O)Nc1ccc(C(OC(=O)C(F)(F)F)(c2ccc(NC(=O)[C@](C)(NC(=O)Cc3c(C)[nH]c4ccccc34)c3ccccn3)cc2)c2ccc(NC(=O)[C@](C)(NC(=O)Cc3c(C)[nH]c4ccccc34)c3ccccn3)cc2)cc1)c1ccccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK6 Q92876 4/20 0.41
MAPT P10636 4/20 0.37
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 4/20 0.37
GAA P10253 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
KMT2A Q03164 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
PRSS1 P07477 2/20 0.36
PRSS2 P07478 2/20 0.36
PRSS3 P35030 2/20 0.36
NTRK1 P04629 1/20 0.35
KLK7 P49862 1/20 0.35
KLK14 Q9P0G3 1/20 0.35
KLK5 Q9Y337 1/20 0.35
IMPDH2 P12268 2/20 0.35
MEN1 O00255 2/20 0.35
RORC P51449 1/20 0.34
HDAC3 O15379 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6290397 0.90 HDAC1 (0.43) MAPTALDH1A1GAAKMT2ATDP1
SCHEMBL6288054 0.90 KLK6 (0.43) KLK6MAPTKDM4EALDH1A1GAA
SCHEMBL6287905 0.86 ANO1 (0.45) MAPTALDH1A1GAAKMT2AMEN1
SCHEMBL6290560 0.85 KLK6 (0.42) KLK6MAPTKDM4EALDH1A1GAA
SCHEMBL6290835 0.84 KLK6 (0.41) KLK6MAPTKDM4EALDH1A1GAA
SCHEMBL6286578 0.80 RORC (0.39) KDM4EKMT2ATDP1MEN1RORC
SCHEMBL6290998 0.79 AKR1C2 (0.44) MAPTALDH1A1GAAKMT2ATDP1
SCHEMBL6287370 0.75 ANO1 (0.46) MAPTALDH1A1GAAKMT2AMEN1
SCHEMBL6291017 0.74 AKR1C2 (0.47) MAPTKDM4EALDH1A1GAAKMT2A
SCHEMBL6285418 0.73 HDAC1 (0.42) KLK6MAPTKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK KLK6 2680/4885MAPT 4866/4885KDM4E 2972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.